These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 23519281)

  • 1. Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.
    Demoro B; de Almeida RF; Marques F; Matos CP; Otero L; Costa Pessoa J; Santos I; Rodríguez A; Moreno V; Lorenzo J; Gambino D; Tomaz AI
    Dalton Trans; 2013 May; 42(19):7131-46. PubMed ID: 23519281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
    Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
    Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
    Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.
    Tomaz AI; Jakusch T; Morais TS; Marques F; de Almeida RF; Mendes F; Enyedy EA; Santos I; Pessoa JC; Kiss T; Garcia MH
    J Inorg Biochem; 2012 Dec; 117():261-9. PubMed ID: 22877927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of biomolecular interactions and cytotoxic activity of organometallic binuclear Ru(II) complexes of ferrocenyl thiosemicarbazones.
    Khanvilkar P; Dash SR; Vohra A; Devkar R; Chakraborty D
    J Biomol Struct Dyn; 2021 Oct; 39(16):6044-6055. PubMed ID: 32729376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.
    Sommer MG; Kureljak P; Urankar D; Schweinfurth D; Stojanović N; Bubrin M; Gazvoda M; Osmak M; Sarkar B; Košmrlj J
    Chemistry; 2014 Dec; 20(52):17296-9. PubMed ID: 25376425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity.
    Demoro B; Bento-Oliveira A; Marques F; Costa Pessoa J; Otero L; Gambino D; F M de Almeida R; Tomaz AI
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
    Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
    J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
    Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
    Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis and antiparasitic activity of aryl- and ferrocenyl-derived thiosemicarbazone ruthenium(II)-arene complexes.
    Adams M; Li Y; Khot H; De Kock C; Smith PJ; Land K; Chibale K; Smith GS
    Dalton Trans; 2013 Apr; 42(13):4677-85. PubMed ID: 23361649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexes.
    Purkait K; Chatterjee S; Karmakar S; Mukherjee A
    Dalton Trans; 2016 May; 45(20):8541-55. PubMed ID: 27120485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex.
    Morais TS; Santos F; Côrte-Real L; Marques F; Robalo MP; Madeira PJ; Garcia MH
    J Inorg Biochem; 2013 May; 122():8-17. PubMed ID: 23416310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and anticancer activity of a series of ketone-N(4)-substituted thiosemicarbazones and their ruthenium(II) arene complexes.
    Su W; Qian Q; Li P; Lei X; Xiao Q; Huang S; Huang C; Cui J
    Inorg Chem; 2013 Nov; 52(21):12440-9. PubMed ID: 24143913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution equilibrium, structural and cytotoxicity studies on Ru(η
    Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
    J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones.
    Demoro B; Rossi M; Caruso F; Liebowitz D; Olea-Azar C; Kemmerling U; Maya JD; Guiset H; Moreno V; Pizzo C; Mahler G; Otero L; Gambino D
    Biol Trace Elem Res; 2013 Jun; 153(1-3):371-81. PubMed ID: 23564472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
    J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.